Epi-Minder
Date | Investors | Amount | Round |
---|---|---|---|
AUD10.0m | Early VC | ||
N/A | Spinout | ||
* | AUD18.0m | Series A | |
* | AUD16.0m | Early VC | |
Total Funding | €25.9m |
Recent News about Epi-Minder
EditEpiminder is a healthcare technology company focused on improving the lives of individuals with epilepsy through advanced monitoring solutions. The company operates in the medical device market, targeting patients diagnosed with epilepsy, particularly those who have not responded well to traditional treatments. Epiminder's core product is a sub-scalp EEG monitoring device that continuously records brain electrical activity, providing valuable data to healthcare providers. This data helps in better understanding and managing epileptic seizures, leading to more effective treatment plans. The business model revolves around selling these devices to hospitals, clinics, and directly to patients, generating revenue through device sales and potentially through data analytics services in the future. Epiminder aims to empower patients by giving them greater control over their condition and reducing the uncertainties associated with epilepsy.
Keywords: epilepsy, sub-scalp EEG, continuous monitoring, brain activity, healthcare technology, medical device, patient empowerment, seizure management, data analytics, refractory patients.